Biotech Shake-Up: New CEO Takes Helm at Jubilant Therapeutics
YARDLEY, PA — Jubilant Therapeutics Inc. has appointed Daniel J. O’Connor as its new president and chief executive officer, effective December 1, 2025, marking a major leadership shift as the …
Biotech Shake-Up: New CEO Takes Helm at Jubilant Therapeutics Read More